Premedication for Claustrophobic Patients for MRI Scan

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-99
SponsorSalem Anaesthesia Pain Clinic

About this trial

Claustrophobia is an irrational fear of restriction and suffocation. It is a specific phobia, according to DSM 5. Claustrophobic patients may fear that restriction of their limbs will hinder their ability to move quickly towards safety. MRI may trigger claustrophobia, because this diagnostic procedure involves a patient laying in a narrow tube. Premedication before MRI scan may occasionally reduce claustrophobia.

Prospective observational crossover study of claustrophobic patients who are undergoing MRI scan. At alternate MRI scan sessions, each patient receives rotational premedication using Lorazepam 1mg; or Clonidine tablet 0.2mg; or combined Clonidine 0.2mg + Lorazepam 1mg.

Patient will use Claustrophobia Questionnaire, a validated tool, to collect data on the days before and after each MRI scan. CLQ is a patient-administered tool used to assess claustrophobia. In addition, patient will use General Anxiety Disorder Questionnaire, a validated tool, to collect data on the days before and after each MRI scan. GAD-7 is a patient-administered tool that is used to assess anxiety.

Eligibility criteria

Qualifiers

diagnosed with claustrophobia

previous incomplete MRI because of claustrophobia

adult patients

good treatment compliance

Disqualifiers

poor treatment compliance

cognitive disorder

inability to provide consent

major neuropsychiatric disorder

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

50 Participants
are grouped into 1 trial group

Sponsors and collaborators